UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst Pharmaceuticals on Positive Expectations for Oral HAE Drug
March 10, 2014 at 09:11 AM EDT
In a report published Monday, H.C. Wainwright & Co. analyst Andrew S. Fein initiated coverage on BioCryst Pharmaceuticals (NASDAQ: BCRX) ...